Literature DB >> 9481747

Mixed cryoglobulinaemia, glomerulonephritis, and ANCA: essential cryoglobulinaemic vasculitis or ANCA-associated vasculitis?

P Lamprecht1, W H Schmitt, W L Gross.   

Abstract

Antineutrophil cytoplasmic antibodies (ANCA) are generally believed to be strongly associated with some primary systemic vasculitides (PSV), such as Wegener's granulomatosis (WG), microscopic polyangiitis (MPA), and Churg-Strauss syndrome (CSS), which have some clinical manifestations in common and are 'pauci-immune' by immunohistology. This group of PSV has thus been termed 'ANCA-associated vasculitis' (AAV). By contrast, essential mixed cryoglobulinaemic vasculitides (EMC) are clinically heterogeneous and characterized immunologically by complement consumption and by immunocomplex depositions; they are also characteristically ANCA-negative. We report here on two SV-patients in whom the detection of cANCA (proteinase 3-ANCA in one case) in conjunction with glomerulonephritis and various extrarenal vasculitic lesions was suggestive of an AAV. However, demonstration of type II cryoglobulinaemia in conjunction with hypocomplementaemia, and histological proof of immunocomplexes in the glomerulus led to the diagnosis of an EMC, which was associated with hepatitis C virus (HCV) infection in one of the cases. Against the setting of 'false positive' cANCA in EMC, we discuss the differential diagnostic steps as well as current differential therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9481747     DOI: 10.1093/ndt/13.1.213

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

Review 1.  Clinical utility of testing for antineutrophil cytoplasmic antibodies.

Authors:  D Vassilopoulos; G S Hoffman
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

2.  Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge.

Authors:  Branka Bonaci-Nikolic; Sladjana Andrejevic; Milorad Pavlovic; Zoran Dimcic; Branislava Ivanovic; Milos Nikolic
Journal:  Clin Rheumatol       Date:  2010-03-20       Impact factor: 2.980

3.  MPO-ANCA associated crescentic glomerulonephritis with numerous immune complexes: case report.

Authors:  Ryuji Morizane; Konosuke Konishi; Akinori Hashiguchi; Hirobumi Tokuyama; Shu Wakino; Hiroshi Kawabe; Matsuhiko Hayashi; Koichi Hayashi; Hiroshi Itoh
Journal:  BMC Nephrol       Date:  2012-06-01       Impact factor: 2.388

Review 4.  Glomerular disease in patients with infectious processes developing antineutrophil cytoplasmic antibodies.

Authors:  Konstantin N Konstantinov; Suzanne N Emil; Marc Barry; Susan Kellie; Antonios H Tzamaloukas
Journal:  ISRN Nephrol       Date:  2013-02-19

5.  Antineutrophil Cytoplasmic Antibody Induction due to Infection: A Patient with Infective Endocarditis and Chronic Hepatitis C.

Authors:  Fareed B Kamar; T Lee-Ann Hawkins
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-03-21       Impact factor: 2.471

6.  An Autopsy Case of Myeloperoxidase-anti-neutrophil Cytoplasmic Antibody (MPO-ANCA)-associated Vasculitis Accompanied by Cryoglobulinemic Vasculitis Affecting the Kidneys, Skin, and Gastrointestinal Tract.

Authors:  Jumpei Hasegawa; Sachiko Wakai; Momoko Kono; Yusuke Imaizumi; Sakiko Masuda; Akihiro Ishizu; Kazuho Honda
Journal:  Intern Med       Date:  2018-04-27       Impact factor: 1.271

7.  Case Report: Patient with Hepatitis C, p-ANCA, and Cryoglobulin Antibodies Presenting with Necrotizing Crescentic p-ANCA Glomerulonephritis.

Authors:  Ramy M Hanna; Naomi So; Marian Kaldas; Jean Hou; Farid Arman; Michelle Sangalang; Bishoy Yanny; Umut Selamet; Sammy Saab; Niloofar Nobakht; Anjay Rastogi
Journal:  Case Rep Nephrol Dial       Date:  2018-08-10

8.  Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients.

Authors:  Soledad Retamozo; Cándido Díaz-Lagares; Xavier Bosch; Albert Bové; Pilar Brito-Zerón; Maria-Eugenia Gómez; Jordi Yagüe; Xavier Forns; Maria C Cid; Manuel Ramos-Casals
Journal:  Medicine (Baltimore)       Date:  2013-09       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.